Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 951 of 1,261

  1. US 8022057

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  2. US 8022052

    Inhibition of PPAR gamma expression by specific osteogenic oxysterols

    The Regents of the University of California · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  3. US 8022040

    Hydroxyapatite-binding peptides for bone growth and inhibition

    The Regents of the University of California · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  4. US 8021874

    Very long chain polyunsaturated fatty acids, methods of production, and uses

    The Board of Regents of the University of Oklahoma · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  5. US 8021671

    Pro-apoptotic bacterial vaccines to enhance cellular immune responses

    The United States of America as represented by the Department of Veteran Affairs · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  6. US 8021646

    Compositions and methods for magnetic resonance imaging contrast agents

    Northwestern University · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  7. US 8021673

    Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

    The Regents of the University of California · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  8. US 8017149

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  9. US 8017781

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  10. US 8017762

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  11. US 8017745

    Plasmodium falciparum antigens and methods of use

    United States of America as represented by the Secretary of the Air Force · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  12. US 8017636

    1,2,4-Oxadiazole benzoic acid compositions and their use in bioassays

    PTC THERAPEUTICS, INC. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  13. US 8017617

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  14. US 8017578

    Orally active peptides that prevent cell damage and death

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  15. US 8017155

    Methods for encapsulation of biomacromolecules in polymers

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  16. US 8017321

    Gefitinib sensitivity-related gene expression and products and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  17. US 8017151

    Amphiphilic polymer-protein conjugates and methods of use thereof

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  18. US 8017619

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  19. US 8017135

    Lipid-drug conjugates for local therapy of eye diseases

    The Regents of the University of California · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  20. US 8017783

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  21. US 8017763

    Chemically modified oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  22. US 8017130

    Method of accelerated vaccination against Ebola viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  23. US 8012699

    Recombinant antigens for diagnosis and prevention of murine typhus

    United States of America as represented by the Secretary of the Air Force · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  24. US 8012493

    Malaria vaccines

    The United States of America as represented by the Secretary of the Army · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.